In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
Objective There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in humans and assess antibiotic efficacy. We aim to inves...
Main Authors: | Sally Ellis, Evelina Tacconelli, Laura Piddock, Luigia Scudeller, Elda Righi, Elena Carrara, Maurizio Sanguinetti, Margherita Chiamenti, Kamilia Abdelraouf, Thomas Lodise, Alessia Savoldi, Dario Menghin, Gloria Pellizzari, Francois Franceschi, Chiara Rebuffi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Open Science |
Online Access: | https://openscience.bmj.com/content/4/1/e100055.full |
Similar Items
-
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies
by: Alessia Savoldi, et al.
Published: (2021-06-01) -
Association of Carbapenem and Colistin Resistance in Pathogenic Gram Negative Bacteria
by: Reham Osama, et al.
Published: (2019-06-01) -
The role of β-lactamases in carbapenem-resistant Gram-negative bacteria
by: Walker, Rachel Anne
Published: (1999) -
Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
by: Bassam El Hafi, et al.
Published: (2019-04-01) -
Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections.
by: Ying P Tabak, et al.
Published: (2020-01-01)